Adenosine release upon spinal cord injury

Brain Research

Volumn 854, Issue 1-2, 2000, Pages 152-157

  McAdoo, David J ^a   Robak, Gregory ^a   Xu, Guo Ying ^a   Hughes, Michael G ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Adenosine; Excitatory amino acid; Microdialysis; Spinal cord injury; Theophylline

Indexed keywords

4 AMINOBUTYRIC ACID; 8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE; EXCITATORY AMINO ACID; GLUTAMIC ACID; THEOPHYLLINE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICRODIALYSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY;

ADENOSINE; ANIMALS; GLUTAMIC ACID; MICRODIALYSIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; SPINAL CORD INJURIES; THEOPHYLLINE;

EID: 0033959045     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02333-1     Document Type: Article

References (47)

1. Akpek E.A., Bulutcu E., Alanay A., Korkusuz P., Acaroglu E., Kilinc K., Ors U. A study of adenosine treatment in experimental acute spinal cord injury. Effect on arachidonic acid metabolites. Spine. 24:1999;128-132.
2. Allen A.R. Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocation of spinal column. J. Am. Med. Assoc. 57:1911;878-880.
3. Bell M.J., Kochanek P.M., Carcillo J.A., Mi Z., Schiding J.K., Wisniewski S.R., Clark R.S.B., Dixon C.E., Marion D.W., Jackson E. Interstitial adenosine, inosine, and hypoxanthine are increased after experimental traumatic brain injury in the rat. J. Neurotrauma. 15:1998;163-170.
4. Benveniste H., Hansen A.J., Ottosen N.S. Determination of brain interstitial concentrations by microdialysis. J. Neurochem. 52:1989;1741-1750.
5. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
6. Clark G.D. Role of excitatory amino acids in brain injury caused by hypoxia-ischemia, status epilepticus, and hypoglycemia. Clin. Perinatol. 16:1989;459-474.
7. Dora C.D., Koch S., Sanchez A., Ruenes G., Liu S., Yezierski R.P. J. Neurotrauma. 15:1998;473-483.
8. Dux E., Fastbom J., Ungerstedt U., Rudolphi K., Fredholm B.B. Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus. Brain Res. 516:1990;248-256.
9. Faden A.I., Simon R.P. Potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann. Neurol. 23:1988;623-626.
10. Fern R., Waxman S.G., Ransom B.R. Modulation of anoxic injury in CNS white matter by adenosine and interaction between adenosine and GABA. J. Neurophysiol. 72:1994;2609-2616.
11. Fredholm B.B., Dunwiddie T.V. How does adenosine inhibit transmitter release? Trends Pharmacol. Sci. 9:1988;130-134.
12. Gerber U.R., Greene R.W., Haas H.L., Stevens D.R. Characterization of inhibition mediated by adenosine in the hippocampus of the rat in vitro. J. Physiol. London. 417:1989;567-578.
13. Globus M.Y.-T., Ginsberg M.D., Busto R. Excitotoxic index - a biochemical marker of selective vulnerability. Neurosci. Lett. 127:1991;39-42.
14. Gruner J.A. A monitored contusion model of spinal cord injury in the rat. J. Neurotrauma. 9:1992;123-128.
15. Hagberg H., Andersson P., Lacarewicz J., Jacobson I., Butcher S., Sandberg M. Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J. Neurochem. 49:1987;227-231.
16. Headrick J.P., Bendall M.R., Faden A.I., Vink R. Dissociation of adenosine levels from bioenergetic state in experimental brain trauma: potential role in secondary injury. J. Cereb. Blood Flow Metab. 14:1994;853-861.
17. Herold J.A., Langenburg S.E., Tribble C.G. Complete prevention of postischemic spinal cord injury by means of regional infusion with hypothermic saline and adenosine. J. Thorac. Cardiovasc. Surg. 107:1994;536-542.
18. Heron A., Lasbennes F., Seylaz J. Adenosine modulation of amino acid release in rat hippocampus during ischemia and veratridine depolarization. Brain Res. 608:1993;27-32.
19. Hirai H., Okada Y. Adenosine facilitates glutamate release in a protein kinase-dependent manner in superior colliculus slices. Eur. J. Pharmacol. 256:1994;65-71.
20. Hirai H., Okada Y. Adenosine facilitates in vivo neurotransmission in the superior colliculus of the rat. J. Neurophysiol. 74:1995;950-960.
21. Jacobson I., Sandberg M., Hamberger A. Mass transfer in brain dialysis devices - a new method for the estimation of extracellular amino acids concentration. J. Neurosci. Methods. 15:1985;263-268.
22. + in rat hippocampus. Brain Res. 658:1994;39-48.
23. 2+ concentration in isolated nerve terminals following metabolic inhibition: possible relevance to hypoglycaemia and anoxia. Neuroscience. 27:1988;175-182.
24. Kochanek P.M., Clark R.S.B., Obrist W.D., Carcillo J.A., Jackson E.K., Mi Z., Wisniewski S.R., Bell M.J., Marion D.W. The role of adenosine during the period of delayed cerebral swelling after severe traumatic brain injury in humans. Acta Neurochir. 70:1997;109-111.
25. Liu D., McAdoo D.J. An experimental model combining microdialysis with electrophysiology, histology, and neurochemistry for exploring mechanisms of secondary damage in spinal cord injury: effects of potassium. J. Neurotrauma. 10:1993;349-361.
26. D. Liu, D.J. McAdoo, A microdialysis model for identifying agents of secondary damage in spinal cord injury, in: S.T. Ohnishi, T. Ohnishi (Eds.), CRC Series in Membrane-Linked Diseases Central Nervous System Trauma Research Techniques, Chap. 29, CRC Press, New York, 1995, pp. 405-413.
27. Liu D., Thangnipon W., McAdoo D.J. Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord. Brain Res. 547:1991;344-348.
28. Liu D., Xu G.-Y., Pan E., McAdoo D.J. Neurotoxicity of glutamate at the concentration released upon spinal cord injury. Neuroscience. 93:1999;1383-1389.
29. Lönnroth P., Jansson P.-A., Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am. J. Physiol. 253:1987;E228-E231.
30. Manzoni O.J., Manabe T., Nicoll R.A. Release of adenosine by activation of NMDA receptors in the hippocampus. Science. 265:1994;2098-2101.
31. Matuszewski B.K., Givens R.S., Srinivasachar K., Carlson R.G., Higuchi T. N-substituted 1-cyanobenz[f]isoindole: evaluation of fluorescence efficiencies of a new fluorogenic label for primary amines and amino acids. Anal. Chem. 59:1987;1102-1105.
32. Miller L.P., Hsu C. Therapeutic potential for adenosine receptor activation in ischemic brain injury. J. Neurotrauma. 9:1992;S563-S577.
33. De Montigny P., Stobaugh J.F., Givens R.S., Carlson R.G., Srinivasachar K., Sternson L.A., Higuchi T. Naphthalene-2,3-dicarboxaldehyde/cyanide ion: a rationally designed fluorogenic reagent for primary amines. Anal. Chem. 59:1987;1096-1101.
34. Morrison P.F., Bungay P.M., Ball J.K., Mefford I.N., Dedrick R.L. Quantitative microdialysis: analysis of transients and application to pharmacokinetics in brain. J. Neurochem. 57:1991;103-119.
35. Muir K.W., Lees K.R. Clinical experience with excitatory amino acid antagonist drugs. Stroke. 26:1995;503-513.
36. Nilsson P., Hillered L., Ponten U., Ungerstedt U. Changes in cortical extracellular levels of energy-related metabolites and amino acids following concussive brain injury in rats. J. Cereb. Blood Flow Metab. 10:1990;631-637.
37. Okada Y., Ozawa S. Inhibitory action of adenosine on synaptic transmission in the hippocampus of the guinea pig in vitro. Eur. J. Pharmacol. 68:1980;483-492.
38. Olney J.W., Farber M.N.B. NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuropsychopharmacology. 13:1995;335-345.
39. 2 adenosine receptor agonist CGS21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex. Neurosci. Lett. 138:1992;169-172.
40. Panter S.S., Yum S.W., Faden A.I. Alteration in extracellular amino acids after traumatic spinal cord injury. Ann. Neurol. 27:1990;96-99.
41. Phillis J.W., Walter G.A., Simpson R.E. Brain adenosine and transmitter amino acid release from the ischemic rat cerebral cortex: effects of the adenosine deaminase inhibitor deoxycoformycin. J. Neurochem. 56:1991;644-650.
42. Rudolphi K.A., Schubert P., Parkinson F.E., Fredholm B.B. Adenosine and brain ischemia. Cereb. Brain Metab. Rev. 4:1992;346-369.
43. Simpson R.E., O'Regan M.H., Perkins L.M., Phillis J.W. Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists. J. Neurochem. 58:1992;1683-1690.
44. Sorkin L.S., Steinman J.L., Hughes M.G., Willis W.D., McAdoo D.J. Microdialysis recovery of serotonin released in spinal cord dorsal horn. J. Neurosci. Methods. 23:1988;131-138.
45. Szatkowski K., Attwell D. Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms. Trends Neurosci. 17:1994;359-365.
46. Wojcik W.J., Neff N.H. Adenosine measurement by a rapid HPLC-fluorometric method: induced changes of adenosine content in regions of at brain. J. Neurochem. 39:1982;280-282.
47. Xu G.-Y., McAdoo D.J., Hughes M.G., Robak G., de Castro R. Jr. Considerations in the determination by microdialysis of resting extracellular amino acid concentrations and release upon spinal cord injury. Neuroscience. 86:1998;1011-1021.